Granahan Investment Management - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,488,139
-39.2%
205,191
-21.6%
0.23%
-29.8%
Q2 2023$10,678,855
+10.5%
261,865
+1.0%
0.33%
+11.9%
Q1 2023$9,663,515
+27.3%
259,284
+19.1%
0.29%
+26.7%
Q4 2022$7,592,866
-10.0%
217,623
+44.3%
0.23%
-15.9%
Q3 2022$8,441,000
-0.8%
150,835
-8.2%
0.28%
-4.8%
Q2 2022$8,506,000
+26.4%
164,345
+77.5%
0.29%
+73.7%
Q1 2022$6,730,000
-50.8%
92,609
-20.0%
0.17%
-40.8%
Q4 2021$13,690,000
-45.4%
115,783
-38.1%
0.28%
-40.8%
Q3 2021$25,084,000
-31.4%
186,985
-17.2%
0.48%
-30.1%
Q2 2021$36,560,000
+117.6%
225,803
+7.8%
0.68%
+91.3%
Q1 2021$16,805,000
+152.9%
209,389
+71.4%
0.36%
+138.9%
Q4 2020$6,645,000
+351.4%
122,143
+65.0%
0.15%
+198.0%
Q3 2020$1,472,000
-8.2%
74,034
-3.0%
0.05%
-13.8%
Q2 2020$1,604,000
+120.9%
76,305
+28.6%
0.06%
+48.7%
Q1 2020$726,000
-17.7%
59,342
-1.3%
0.04%
-4.9%
Q4 2019$882,000
+10.7%
60,107
+0.7%
0.04%
-6.8%
Q3 2019$797,000
-11.7%
59,691
+8.2%
0.04%
-2.2%
Q2 2019$903,000
-6.8%
55,163
-2.8%
0.04%
-13.5%
Q1 2019$969,000
+16.7%
56,760
-6.7%
0.05%
-11.9%
Q4 2018$830,000
-64.8%
60,834
-26.1%
0.06%
-53.9%
Q3 2018$2,357,000
-28.6%
82,359
-31.7%
0.13%
-35.7%
Q2 2018$3,301,000
+41.7%
120,645
+9.2%
0.20%
+18.5%
Q1 2018$2,329,000
-7.2%
110,442
-15.4%
0.17%
-14.7%
Q4 2017$2,510,000
-64.7%
130,608
-54.4%
0.20%
-66.8%
Q3 2017$7,111,000
+66.2%
286,144
+7.0%
0.59%
+50.5%
Q2 2017$4,278,000267,3600.39%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders